MedTrace Logo

Perioperative Counselling and Parental Awareness of Second-hand Smoke

NCT07144982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2025-08-28

No results posted yet for this study

Summary

In a single-centre observational before-after study (n=31 parental smokers), a standardized \~15-minute tobacco-counselling intervention delivered during the paediatric ambulatory pathway significantly increased parental awareness of secondhand-smoke harms (median total score 34→46; p=0.0026). Item-level gains were greatest for perceived anaesthetic risk and misconceptions about tertiary/indirect exposure. Session acceptability was high, but self-reported behavioural change at 30 days was limited. The perioperative consultation is a feasible "teachable moment"; integration with visual aids, objective exposure measures, structured cessation referral and longitudinal follow-up should be considered to translate awareness into sustained exposure reduction.

Conditions

  • Secondhand Smoke Exposure

Interventions

BEHAVIORAL

Counselling session

Each enrolled parent received a single, standardized counselling session (\~15 minutes) delivered in the ambulatory unit by a certified tobacco counsellor. The session followed a fixed script and covered: (1) types of tobacco smoke exposure (primary, secondary and tertiary), (2) health consequences for children with emphasis on perioperative respiratory and anaesthetic risks, (3) practical measures to reduce household exposure (smoke-free home/car rules, behavioural strategies), and (4) brief advice on initial cessation steps and referral options. Structured handouts and signposting to support services were offered when appropriate.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-07
Primary Completion
2025-03-27
Completion
2025-03-27

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07144982 on ClinicalTrials.gov